Nexus Uranium Corp., classified in the Chemicals sector, is a listed company. Its insiders report their share dealings to SEDI. 4 insiders have disclosed 11 filings since 21 October 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Across the 2,475 companies tracked on its exchange, the median is 12 filings; at 11 filings, this issuer sits below that mark.
Over the last twelve months, not one insider purchase of Nexus Uranium Corp. stock was filed. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public.
Elsewhere in the same sector, our signals recently picked up insider purchases at Fuller H B Co and Culp Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended November 2025 · cache
12 of 12 declarations
Nexus Uranium Corp. is a company focused on the exploration and development of uranium projects in Canada. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 7 filings published between 19 October and 20 October 2026: no open-market purchase or sale filed by an insider. 7 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 21 October 2026 (UTC)